A detailed history of Geode Capital Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,902,636 shares of TECH stock, worth $286 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,902,636
Previous 3,906,378 0.1%
Holding current value
$286 Million
Previous $280 Million 11.42%
% of portfolio
0.03%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$70.96 - $82.35 $265,532 - $308,153
-3,742 Reduced 0.1%
3,902,636 $312 Million
Q2 2024

Aug 09, 2024

BUY
$62.12 - $84.15 $4.23 Million - $5.74 Million
68,168 Added 1.78%
3,906,378 $280 Million
Q1 2024

May 13, 2024

BUY
$65.98 - $77.09 $7.69 Million - $8.98 Million
116,483 Added 3.13%
3,838,210 $270 Million
Q4 2023

Feb 13, 2024

BUY
$52.83 - $78.22 $5.45 Million - $8.07 Million
103,220 Added 2.85%
3,721,727 $287 Million
Q3 2023

Nov 13, 2023

BUY
$67.52 - $89.42 $4.98 Million - $6.6 Million
73,776 Added 2.08%
3,618,507 $246 Million
Q2 2023

Aug 11, 2023

SELL
$73.76 - $85.98 $14.5 Million - $16.9 Million
-196,440 Reduced 5.25%
3,544,731 $289 Million
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $4.69 Million - $5.67 Million
65,432 Added 1.78%
3,741,171 $278 Million
Q4 2022

Feb 13, 2023

BUY
$80.67 - $352.29 $225 Million - $982 Million
2,788,348 Added 314.22%
3,675,739 $304 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $28.4 Million - $39.4 Million
100,557 Added 12.78%
887,391 $252 Million
Q2 2022

Aug 12, 2022

BUY
$322.67 - $449.65 $433,668 - $604,329
1,344 Added 0.17%
786,834 $272 Million
Q1 2022

May 13, 2022

BUY
$353.85 - $487.79 $7.97 Million - $11 Million
22,537 Added 2.95%
785,490 $339 Million
Q4 2021

Feb 11, 2022

BUY
$456.15 - $525.06 $14 Million - $16.1 Million
30,699 Added 4.19%
762,953 $394 Million
Q3 2021

Nov 12, 2021

BUY
$444.87 - $538.88 $76.9 Million - $93.2 Million
172,930 Added 30.92%
732,254 $354 Million
Q2 2021

Aug 13, 2021

BUY
$387.35 - $450.26 $9.35 Million - $10.9 Million
24,149 Added 4.51%
559,324 $252 Million
Q1 2021

May 12, 2021

SELL
$314.62 - $411.0 $8.44 Million - $11 Million
-26,819 Reduced 4.77%
535,175 $204 Million
Q4 2020

Feb 12, 2021

BUY
$246.9 - $321.87 $1.78 Million - $2.32 Million
7,216 Added 1.3%
561,994 $178 Million
Q3 2020

Nov 13, 2020

SELL
$232.22 - $282.96 $5.72 Million - $6.97 Million
-24,622 Reduced 4.25%
554,778 $137 Million
Q2 2020

Aug 13, 2020

BUY
$185.43 - $279.56 $13.6 Million - $20.5 Million
73,360 Added 14.5%
579,400 $153 Million
Q1 2020

May 14, 2020

BUY
$161.17 - $221.51 $2.41 Million - $3.32 Million
14,982 Added 3.05%
506,040 $96 Million
Q4 2019

Feb 13, 2020

BUY
$189.68 - $222.09 $7.36 Million - $8.62 Million
38,825 Added 8.59%
491,058 $108 Million
Q3 2019

Nov 12, 2019

BUY
$183.56 - $216.72 $1.78 Million - $2.1 Million
9,708 Added 2.19%
452,233 $88.5 Million
Q2 2019

Aug 14, 2019

BUY
$188.72 - $215.43 $3.08 Million - $3.52 Million
16,329 Added 3.83%
442,525 $92.3 Million
Q1 2019

May 14, 2019

BUY
$136.09 - $200.44 $1.32 Million - $1.94 Million
9,700 Added 2.33%
426,196 $84.6 Million
Q4 2018

Feb 13, 2019

BUY
$132.75 - $203.8 $3.66 Million - $5.62 Million
27,587 Added 7.09%
416,496 $60.3 Million
Q3 2018

Nov 13, 2018

BUY
$147.44 - $204.11 $5.17 Million - $7.15 Million
35,033 Added 9.9%
388,909 $79.4 Million
Q2 2018

Aug 14, 2018

BUY
$144.9 - $165.58 $1.73 Million - $1.98 Million
11,932 Added 3.49%
353,876 $52.4 Million
Q1 2018

May 15, 2018

BUY
$131.46 - $151.04 $561,597 - $645,242
4,272 Added 1.27%
341,944 $51.6 Million
Q4 2017

Feb 13, 2018

BUY
$121.17 - $134.75 $809,536 - $900,264
6,681 Added 2.02%
337,672 $43.7 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $1.75 Million - $1.91 Million
15,407 Added 4.88%
330,991 $40 Million
Q2 2017

Aug 14, 2017

BUY
N/A
315,584
315,584 $37.1 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.